The Department of Health and Social Care (DHSC) has entered consultation with Community Pharmacy England on the 2026/27 Community Pharmacy Contractual Framework (CPCF). A letter signalling the start of the formal negotiations process was sent to Community Pharmacy England this week. Detailed discussions begin immediately and will cover funding, service changes and other arrangements for
Read moreThe Department of Health and Social Care (DHSC) has today (27/02/2026) confirmed the following list of price concessions for February 2026: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department.
Read moreThe Department of Health and Social Care (DHSC) has today (26/02/2026) confirmed the following list of price concessions for February 2026: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free and Co-trimoxazole 80mg/400mg/5ml oral suspension MSN/2026/016 Tier 2 – medium impact Date of issue: 25 February 2026 Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free will be out of stock from mid-March until June 2026. Co-trimoxazole 80mg/400mg/5ml
Read moreThe reimbursement prices for the first 11 multi-source products moving from Category C to the new Category H have been published in the March 2026 Drug Tariff. Prices for 6 products have increased whereas 5 products have seen a decrease compared to their previous Category C prices. Ursodeoxycholic acid 500mg tablets (100) has the largest
Read moreThe Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 March 2026. Part VIIIA – Basic prices of drugs Contractors should note changes made to the notes to Part VIIIA regarding Categories A, C, H and M.
Read moreA falsified version of Mounjaro (tirzepatide) KwikPen 15mg solution for injection has been found supplied through one online pharmacy in the UK. The falsified product is labelled with batch D873576 and applies to Mounjaro KwikPen 15mg solution for injection in pre-filled pen only. The issue was identified due to faults with the pens, where in
Read moreMHRA Class 4 Medicines Defect Notification: Dropodex 0.1% w/v Eye Drops, solution (Rayner Pharmaceuticals Limited) Drug alert number: EL(26)A/10 Date issued: 24 February 2026 Rayner Pharmaceuticals limited have informed the MHRA that the batches listed in this notification do not include the concentration of phosphates in the product information. DMRC reference number: DMRC-38371734 Marketing Authorisation Holder: Rayner
Read moreMHRA Class 2 Medicines Recall: KidNaps (Melatonin) 1mg in 1ml Oral Solution (Sterling Pharmaceuticals Ltd) Drug alert number: EL(26)A/09 Date issued: 23 February 2026 Sterling Pharmaceuticals Ltd and Veriton Pharma Ltd are recalling all batches of KidNaps (Melatonin) 1mg in 1ml Oral Solution due to out of specification stability results. DMRC reference number: DMRC-38487919 Company name: Sterling
Read moreCommunity Pharmacy England met in London for a full Committee meeting on 4th and 5th February. Committee Members examined economic and other analysis to confirm key negotiating positions for the imminent 2026/27 contractual negotiations, looking at a wide range of topics including funding needs, services, infrastructure investment, and regulatory reform. The Department of Health and Social Care and
Read more
